Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature.
about
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingHuman Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.Unusual mucoepidermoid carcinoma of the liver misdiagnosed as squamous cell carcinoma by intraoperative histological examination.Maintenance therapy with trastuzumab in her2 positive metastatic parotid ductal adenocarcinoma.Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.
P2860
Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Trastuzumab for Her2/neu-posit ...... and review of the literature.
@en
type
label
Trastuzumab for Her2/neu-posit ...... and review of the literature.
@en
prefLabel
Trastuzumab for Her2/neu-posit ...... and review of the literature.
@en
P2093
P2860
P356
P1476
Trastuzumab for Her2/neu-posit ...... and review of the literature.
@en
P2093
Ammar Sukari
Bassel Atassi
Belal Firwana
Nour Hasan
P2860
P356
10.4103/2231-0770.102282
P577
2012-07-01T00:00:00Z